Clinical trial Recruiting at 1 site Interventional Ages 25 to 75

Adaptive daytime DBS parameter optimization for people with Parkinson's disease

Official title: Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Run by University of California, San Francisco · NCT07682311 · Data updated 2026-11-12

This study tests if aMedtronic Percept adaptive DBS can dynamically adjust stimulation in people with Parkinson's who already have DBS hardware.

Quick facts

Study typeInterventional
Ages25 Years to 75 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedJune 4, 2026
Main results expectedMay 2030
Study endsMay 2032
Registry record updatedSeptember 14, 2026
Trial IDNCT07682311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 25-75 with idiopathic Parkinson’s disease, already implanted with the Medtronic Percept DBS, and experiencing residual symptoms on conventional DBS.

Probably not a fit

Patients whose motor fluctuations do not improve with adaptive adjustments or who cannot tolerate changes in stimulation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This non-randomized, intervention study examines whether adaptive deep brain stimulation can automatically adjust stimulation settings in real time for patients with the Medtronic Percept system. Participants have idiopathic Parkinson’s disease, already implanted with cDBS for at least two months, and experience residual motor fluctuations. The study uses neural signals to guide stimulation amplitude and other parameters during daily activities. Outcomes include brain recordings, stimulation testing, and clinical assessments to see if adaptive therapy improves motor control compared with baseline settings. Participants may revert to baseline cDBS settings for the clinical phase as needed.

Why it matters

Potential benefit: If successful, adaptive DBS could reduce motor fluctuations and improve daily functioning for people with Parkinson’s who are already DBS users.

How similar studies have gone: Adaptive DBS approaches have shown promise in some prior studies, but this exact device and protocol are relatively novel within this patient population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 25-75.
2. Diagnosis of idiopathic PD.
3. Patient has undergone surgical intervention with deep brain stimulation (Percept device) for their disorder at least 2 months prior to recruitment.
4. Absence of significant cognitive impairment (score of 24 or greater on the Montreal Cognitive Assessment (MoCA)).
5. Signed informed consent.
6. Ability to comply with study follow-up visits for brain recording, testing of adaptive stimulation, and clinical assessment.
7. Patient has been on cDBS for at least two months and still experiences significant residual motor fluctuation while on cDBS. Consequently, patient is undergoing aDBS treatment currently or was recommended aDBS as part of clinical care to manage their residual motor fluctuation.
8. Has available cDBS Timeline LFP and stimulation data lasting at least 1 day.
9. To be enrolled in the clinical trial phase of the study, patient will need to consent to reverting back to their baseline cDBS settings for all required cDBS testings.

Exclusion Criteria:

1. Patient meets criteria for a psychogenic movement disorder.
2. Significant untreated depression (BDI-II score \>20). History of suicidal attempt or active suicidal ideation (Yes to #2-5 on C-SSRS).
3. Any personality or mood symptoms that study personnel believe will interfere with study requirements.

Where it's running

  • University of California San Francisco
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Simon Little, MBBS,PhD — University of California, San Francisco
  • Study coordinator: Research Coordinator
  • Email: sebastian.liu@ucsf.edu
  • Phone: 5175152739

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Simplified, scalable 24-hour adaptive deep brain stimulation for Parkinson's disease

    This study will test whether a less invasive under‑scalp recording system can drive around‑the‑clock adaptive deep brain stimulation to help people with Parkinson's disease who have motor fluctuations or sleep problems.

    Recruiting University of California, San Francisco · San Francisco, California · NCT07398157

  • Assessing outcomes for freezing of gait in Parkinson's disease

    This study is trying to find better ways to measure how bad freezing of gait is for people with Parkinson's disease who can walk on their own.

    Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT06519279

  • Transplanting stem cells to treat Parkinson's disease

    This study is testing whether transplanting special stem cells into the brains of people with Parkinson's disease can help improve their symptoms and overall health.

    Recruiting Phase 1 University of California, San Diego · La Jolla, California · NCT06482268

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.